Paper Details

  1. Home
  2. Paper Details

A study of prophylactic use of 15-methyl prostalglandin F2alpha in the active management of third stage of labour.

Author: BalRuna, BiswasArati, HalderModhusudan, KunduMrinal Kanti, KyalAmit

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Active management of the third stage of labor with 15-methyl prostaglandin F2alpha (PGF2alpha) was found to be more effective in reducing the duration of the third stage and the amount of bleeding than conventional management with methylergometrine.
Paper Details　
Original Abstract of the Article :
To compare active management of third stage of labour with 15-methyl prostaglandin F2alpha (PGF2alpha) and conventional management with methylergometrine as prophylaxis for postpartum hemorrhage, a randomised comparative study was carried out at Calcutta National Medical College and Hospital, Kolkat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/18338474

データ提供：米国国立医学図書館（NLM）

Prophylactic 15-Methyl Prostaglandin F2alpha: A Safe and Effective Approach to Postpartum Hemorrhage

Postpartum hemorrhage is a serious complication that can occur after childbirth, posing a significant risk to the mother's health. It's like a sudden and unexpected sandstorm that can quickly escalate into a life-threatening situation. This study investigates the effectiveness of prophylactic 15-methyl prostaglandin F2alpha (PGF2alpha) in preventing postpartum hemorrhage.

PGF2alpha: A Powerful Tool for Prevention

The researchers found that administering PGF2alpha at the time of delivery significantly reduced the duration of the third stage of labor and decreased the amount of bleeding compared to conventional management. It's like having a skilled camel trainer who can anticipate and manage potential risks during a desert journey, ensuring a safe and smooth transition.

Protecting Mothers: A Crucial Step

This study highlights the potential of PGF2alpha as a valuable tool for preventing postpartum hemorrhage, particularly in developing countries where this complication is a major contributor to maternal mortality. It's like having a protective shield against the dangers of a sandstorm, safeguarding mothers from a life-threatening complication.

Dr.Camel's Conclusion

This research demonstrates the effectiveness of PGF2alpha in preventing postpartum hemorrhage, offering a safe and effective way to protect mothers during childbirth. This research is a valuable contribution to improving maternal health outcomes, particularly in resource-limited settings. It's like discovering a new oasis in the desert, offering a sanctuary of safety and well-being for mothers during a critical time in their lives.
Date :
  1. Date Completed 2008-05-07
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

18338474

DOI: Digital Object Identifier

18338474

Related Literature

Article Analysis
・Side Effects of methylergonovine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.